WO2008021463A3 - Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders - Google Patents
Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders Download PDFInfo
- Publication number
- WO2008021463A3 WO2008021463A3 PCT/US2007/018201 US2007018201W WO2008021463A3 WO 2008021463 A3 WO2008021463 A3 WO 2008021463A3 US 2007018201 W US2007018201 W US 2007018201W WO 2008021463 A3 WO2008021463 A3 WO 2008021463A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- analogs
- methods
- cycloheptene
- treatment
- amino substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
Disclosed herein are analogs of clozapine and pharmaceutically acceptable salts, esters, amides, or prodrugs thereof; methods of synthesizing the analogs; and methods of using the analogs for treating neuorpsychiatric disorders. In some embodiments, the analogs are amino substituted diaryl[a,d]cycloheptenes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/370,560 US20090239840A1 (en) | 2003-12-22 | 2009-02-12 | AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83805606P | 2006-08-15 | 2006-08-15 | |
US60/838,056 | 2006-08-15 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/019,555 Continuation US7550454B2 (en) | 2003-12-22 | 2004-12-21 | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008021463A2 WO2008021463A2 (en) | 2008-02-21 |
WO2008021463A3 true WO2008021463A3 (en) | 2008-12-24 |
Family
ID=38819733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/018201 WO2008021463A2 (en) | 2003-12-22 | 2007-08-15 | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008021463A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2746220A1 (en) | 2008-12-08 | 2010-07-08 | Vm Pharma Llc | Compositions of protein receptor tyrosine kinase inhibitors |
US8999992B2 (en) | 2013-03-15 | 2015-04-07 | Vm Pharma Llc | Crystalline forms of tryosine kinase inhibitors and their salts |
ES2754385T3 (en) | 2013-04-23 | 2020-04-17 | Esteve Pharmaceuticals Sa | Pyrazine- [1,2-a] indole compounds, their preparation and use in medicinal products |
RU2610169C2 (en) | 2014-09-11 | 2017-02-08 | Общество С Ограниченной Ответственностью "Валентек" | Derivatives of 7-fluoro-8-chloro-5h-dibenzo [b, e] [1, 4] diazepine and their application |
MX2017003439A (en) | 2014-09-17 | 2017-12-04 | Mundipharma International Corporation Ltd | Crystalline forms of tyrosine kinase inhibitors and their salts. |
TW201831462A (en) * | 2017-01-25 | 2018-09-01 | 日商大日本住友製藥股份有限公司 | Dibenzodiazepine derivative |
CN107903244B (en) * | 2017-11-29 | 2019-06-14 | 武汉珈创生物技术股份有限公司 | 2- amido with anti-tumor activity replaces Benzodiazepine compound and preparation method thereof |
CN108586364B (en) * | 2017-12-28 | 2021-11-09 | 新乡医学院 | Dibenzoazepine compound and preparation method and application thereof |
JP2021104931A (en) * | 2018-02-22 | 2021-07-26 | 大日本住友製薬株式会社 | Dibenzoazepine derivative having nitrogen-containing heterocycle |
AU2020370063A1 (en) | 2019-10-21 | 2022-06-02 | Alairion, Inc. | 3-(4-(llH-dibenzo[b,e][l,4]azepin-6- yl)piperazin-l-yl)- and 3- (4-(dibenzo[b,f][l,4]oxazepin/thiazepin/diazepin-11-yl)piperazin-1-yl)-propano ic acid derivatives as HI and 5- HT2A-receptor modulators for the treatment of sleep disorders |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH493538A (en) * | 1966-12-16 | 1970-07-15 | American Cyanamid Co | 11-aminodibenz b f 1 4-oxa-thia-or dia-zepines |
US3546226A (en) * | 1963-03-01 | 1970-12-08 | A Wander Sa Dr | 11-basic-substituted dibenzoxazepines |
FR2222102A1 (en) * | 1973-03-23 | 1974-10-18 | Wander Ag Dr A | 11-Piperazino dibenzo diazepines neuroleptics - and anti-depressants, prepd. from a dibenzo diazepin-11-one and a piperazine |
WO2005002586A1 (en) * | 2003-07-02 | 2005-01-13 | Astrazeneca Ab | Metabolite of quetiapine |
WO2005063254A2 (en) * | 2003-12-22 | 2005-07-14 | Acadia Pharmaceuticals Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
WO2006107948A2 (en) * | 2005-04-04 | 2006-10-12 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
WO2007062337A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Crystalline forms |
WO2007062339A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Liquid formulations |
WO2007062338A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Solid formulations |
WO2007062336A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Salt forms |
WO2008066620A2 (en) * | 2006-10-20 | 2008-06-05 | Concert Pharmaceuticals Inc. | Dibenzothiazepine derivatives |
-
2007
- 2007-08-15 WO PCT/US2007/018201 patent/WO2008021463A2/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3546226A (en) * | 1963-03-01 | 1970-12-08 | A Wander Sa Dr | 11-basic-substituted dibenzoxazepines |
CH493538A (en) * | 1966-12-16 | 1970-07-15 | American Cyanamid Co | 11-aminodibenz b f 1 4-oxa-thia-or dia-zepines |
FR2222102A1 (en) * | 1973-03-23 | 1974-10-18 | Wander Ag Dr A | 11-Piperazino dibenzo diazepines neuroleptics - and anti-depressants, prepd. from a dibenzo diazepin-11-one and a piperazine |
WO2005002586A1 (en) * | 2003-07-02 | 2005-01-13 | Astrazeneca Ab | Metabolite of quetiapine |
WO2005063254A2 (en) * | 2003-12-22 | 2005-07-14 | Acadia Pharmaceuticals Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
WO2006107948A2 (en) * | 2005-04-04 | 2006-10-12 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
WO2007062337A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Crystalline forms |
WO2007062339A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Liquid formulations |
WO2007062338A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Solid formulations |
WO2007062336A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Salt forms |
WO2008066620A2 (en) * | 2006-10-20 | 2008-06-05 | Concert Pharmaceuticals Inc. | Dibenzothiazepine derivatives |
Also Published As
Publication number | Publication date |
---|---|
WO2008021463A2 (en) | 2008-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005063254A3 (en) | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders | |
WO2008021463A3 (en) | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders | |
EG23719A (en) | New process for the synthesis of (I S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of I V abradine and addition salts thereof witha pharmaceutically acceptable acid | |
WO2008044243A3 (en) | Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof | |
IL195178A0 (en) | 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments | |
IL195177A0 (en) | 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments | |
IL195176A0 (en) | 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments | |
WO2007127505A3 (en) | Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system | |
SI1589005T1 (en) | Process for the synthesis of Ivabradine and its pharmaceutically acceptable acid addition salts | |
SI2024341T1 (en) | Novel process for statins and its pharmaceutically acceptable salts thereof | |
WO2008062276A8 (en) | Acetylene derivatives as stearoyl coa desaturase inhibitors | |
ZA200805839B (en) | Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors | |
LT2234979T (en) | 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, process for their production and their use as anti-inflammatory agents | |
ZA200501468B (en) | Process for the synthesis of 1,3,4,5-tetrahydro-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
WO2009061374A3 (en) | Deuterated fingolimod | |
WO2007109288A3 (en) | Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use | |
WO2010044585A3 (en) | Piperidine compounds, pharmaceutical composition comprising the same and its use | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
IL180311A0 (en) | Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters | |
WO2007126898A8 (en) | Use of ladostigil for the treatment of schizophrenia | |
NZ606276A (en) | Fastening Means | |
ZA200501467B (en) | Process for the synthesis of 1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
WO2006136454A3 (en) | Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease | |
WO2007144699A3 (en) | Process for the preparation of alfuzosin | |
FR2915900B1 (en) | NEW PROCESS FOR THE PREPARATION OF PURIFIED EXTRACTS OF HARPAGOPHYTUM PROCUMBENS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07836943 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07836943 Country of ref document: EP Kind code of ref document: A2 |